What are the causes and treatment options for pericarditis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes and Treatment of Pericarditis

Etiology

Viral infections are the most common cause of pericarditis in developed countries, while tuberculosis dominates globally, especially in endemic regions. 1

Common Causes by Geographic Region

Developed Countries (North America/Western Europe):

  • Idiopathic or viral pericarditis (most common) - caused by enteroviruses, herpesviruses, parvovirus B19, influenza viruses, and HIV 1, 2
  • Post-cardiac injury syndromes following cardiac surgery, percutaneous coronary interventions, pacemaker insertion, and catheter ablation 1

Developing Countries/Endemic Areas:

  • Tuberculous pericarditis accounts for >90% of cases in HIV-infected individuals and 50-70% in non-HIV-infected individuals 1

Other Important Causes

  • Autoimmune disorders including systemic lupus erythematosus, rheumatoid arthritis, and systemic sclerosis 1
  • Neoplastic pericarditis from primary tumors or metastatic disease (lung cancer, breast cancer, lymphoma, leukemia) 1
  • Bacterial pericarditis from Staphylococcus, Streptococcus, Haemophilus, or Mycobacterium tuberculosis, occurring via direct infection during trauma/surgery, spread from intrathoracic foci, or hematogenous dissemination 3

First-Line Treatment

Aspirin or ibuprofen combined with colchicine is the recommended first-line therapy for acute pericarditis. 4, 5

NSAIDs/Aspirin Dosing

  • Aspirin: 750-1000 mg every 8 hours for 1-2 weeks 4, 5
  • Ibuprofen: 600 mg every 8 hours for 1-2 weeks 4, 5
  • Gastroprotection is mandatory with all NSAID therapy 4, 5
  • Treatment duration should be guided by symptom resolution and C-reactive protein (CRP) normalization 4, 5
  • Tapering is essential: Decrease aspirin by 250-500 mg every 1-2 weeks or ibuprofen by 200-400 mg every 1-2 weeks 4, 5

Colchicine (Must Be Added to NSAIDs)

  • Weight-adjusted dosing: 0.5 mg once daily if <70 kg OR 0.5 mg twice daily if ≥70 kg 4, 5
  • Duration: 3 months minimum 4, 5
  • Colchicine reduces recurrence risk from 37.5% to 16.7% (absolute risk reduction 20.8%) 2
  • Tapering is not mandatory but may use 0.5 mg every other day (<70 kg) or 0.5 mg once daily (≥70 kg) in final weeks 4

Second-Line Treatment

Corticosteroids should only be used when NSAIDs/colchicine fail or are contraindicated, and NEVER as first-line therapy. 4, 5, 1

Corticosteroid Use

  • Low to moderate doses only: Prednisone 0.2-0.5 mg/kg/day 4, 5, 1
  • Must exclude infectious causes before initiating 1
  • Always combine with colchicine when using corticosteroids 4
  • Major caveat: Corticosteroids increase risk of chronicity, recurrence, and drug dependence 4, 5, 1

Treatment Algorithm by Risk Stratification

High-Risk Features Requiring Admission

  • Fever >38°C (100.4°F) 4
  • Subacute course (symptoms over several days without clear acute onset) 4
  • Large pericardial effusion (diastolic echo-free space >20 mm) 4
  • Cardiac tamponade 4
  • Failure to respond to NSAIDs within 7 days 4
  • Myopericarditis, immunosuppression, trauma, or oral anticoagulant therapy 4

Low-Risk Cases

  • Outpatient management with NSAIDs + colchicine 4, 5
  • Monitor CRP to guide treatment duration and assess response 5

Moderate-Risk Cases

  • Admission and etiology search 4

Activity Restriction

Physical activity must be restricted beyond ordinary sedentary life until complete resolution. 4, 5

  • Restriction continues until symptoms resolve AND CRP, ECG, and echocardiogram normalize 4, 5
  • For athletes: Minimum 3-month restriction from competitive sports after initial onset 4, 5
  • For non-athletes: Restriction until remission is achieved 4

Specific Etiologies Requiring Targeted Therapy

Tuberculous Pericarditis

  • Initial treatment: Isoniazid 300 mg/day, rifampin 600 mg/day, pyrazinamide 15-30 mg/kg/day, and ethambutol 15-25 mg/kg/day 3
  • Prednisone 1-2 mg/kg/day for 5-7 days, then progressively reduced over 6-8 weeks 3
  • Drug sensitivity testing is essential 3
  • Mortality approaches 85% if untreated 3

Purulent/Bacterial Pericarditis

  • Urgent pericardial drainage is mandatory 3
  • Intravenous antibiotics: Vancomycin 1g twice daily, ceftriaxone 1-2g twice daily, and ciprofloxacin 400 mg/day 3
  • Open surgical drainage is preferable to catheter drainage 3
  • Mortality rate is 40% even with treatment 3

Histoplasma Pericarditis

  • Antifungal therapy is NOT recommended 4
  • NSAIDs for 2-12 weeks based on clinical resolution 4
  • Corticosteroids may be tried for 1-2 weeks if hemodynamic compromise, followed by NSAIDs 4
  • If corticosteroids used, consider concurrent itraconazole 200 mg once or twice daily for 12 weeks 4
  • Percutaneous or surgical drainage for pericardial tamponade 4

Refractory Recurrent Pericarditis

For patients with multiple recurrences refractory to conventional therapy, IL-1 antagonists are highly effective. 5, 2, 6

  • Anti-IL-1 agents (anakinra, rilonacept) reduce recurrences from 78% to 10% (RR=0.14) 6
  • Consider after failure of NSAIDs, colchicine, and corticosteroids 7, 2
  • Alternative options include azathioprine or intravenous immunoglobulins 4
  • Pericardiectomy is a last resort for truly refractory cases 4

Critical Pitfalls to Avoid

  • Inadequate treatment of the first episode is the most common cause of recurrence 5
  • Never use corticosteroids as first-line therapy - they provide rapid symptom relief but dramatically increase recurrence risk 4, 5, 1
  • Never taper medications until symptoms are absent AND CRP is normalized 5
  • Recurrence rates: 15-30% after first episode without colchicine, rising to 50% after first recurrence 5, 2, 6
  • For first recurrence, extend colchicine to at least 6 months 2

Prognosis by Etiology

Constrictive Pericarditis Risk

  • Low risk (<1%): Idiopathic/viral pericarditis 5, 1
  • Intermediate risk (2-5%): Autoimmune/neoplastic causes 5, 1
  • High risk (20-30%): Bacterial pericarditis 5, 1

Cardiac Tamponade Risk

  • Rare (<3%) in idiopathic pericarditis 2
  • More common with malignancy, tuberculosis, and purulent pericarditis 1

References

Guideline

Pericarditis Causes and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Bacterial pericarditis: diagnosis and management.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2005

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Initial Treatment for Pericarditis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.